Higher 25‐hydroxyvitamin D is associated with lower relapse risk in multiple sclerosis

Steve Simpson(University of Tasmania), Ingrid van der Mei(University of Tasmania), Fotini Pittas(University of Tasmania), Terence Dwyer(The University of Melbourne), Bruce Taylor(University of London), Anne‐Louise Ponsonby(Royal Children's Hospital), Leigh Blizzard(University of Tasmania), Peter Gies, Helen Tremlett(St. Michael's Hospital)
Annals of Neurology
April 7, 2010
10.1002/ana.22043
Cited by 453

Related Papers

Rising prevalence of multiple sclerosis worldwide: Insights from the Atlas of MS, third edition
|Multiple Sclerosis Journal|2020|2.5k
Vitamin D supplementation to prevent acute respiratory tract infections: systematic review and meta-analysis of individual participant data
|BMJ|2017|2.1k
Childhood Adiposity, Adult Adiposity, and Cardiovascular Risk Factors
|New England Journal of Medicine|2011|1.6k
Atlas of Multiple Sclerosis 2013: A growing global problem with widespread inequity
|Neurology|2014|1.3k
Prevalence of challenge-proven IgE-mediated food allergy using population-based sampling and predetermined challenge criteria in infants
|Journal of Allergy and Clinical Immunology|2011|1k